Market Scope

Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis

Choose Your Experience

Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

11/20/2026
BreakingDealsPharmaRetina
J&J to Acquire Ollin Biosciences for $2.2 Billion Up Front, Plus Milestone Payments
J&J to Acquire Ollin Biosciences for $2.2 Billion Up Front, Plus Milestone Payments
Johnson & Johnson announced Nov. 16 that it would acquire Ollin Biosciences and its retinal treatment candidate OLN324 for $2.2 billion up front, with the potential for up to $1.125 billionin addit...
11/20/2026
BreakingCataractFLACSGlaucomaLaserOcular CancerRevenueSurgical
Q3-2026 Ophthalmic Revenue Roundup for Immunocore, Lensar, and Iridex
Q3-2026 Ophthalmic Revenue Roundup for Immunocore, Lensar, and Iridex
UK-headquartered Immunocore reported Nov. 6 that its Q3-2026 net revenue from Kimmtrak (tebentafusp) was $102.2 million, a 1.4 percent decline from $103.7 million in Q3-2025. Regionally, Kimmtrak n...
11/20/2026
BreakingDeviceEuropeRegulationRetina
MacuMira Gains CE Marking for Microcurrent Treatment for Dry AMD
MacuMira Gains CE Marking for Microcurrent Treatment for Dry AMD
MacuMira Medical Devices, of Calgary, Alberta, reported Nov. 16 that its retinal microcurrent stimulation device had gained CE marking for the treatment of dry age-related macular degeneration (AMD...
11/17/2026
EuropeMeetingNewsletterRetina
Euretina Congress Embraces a Global Role as it Becomes Biggest Retina Meeting
Euretina Congress Embraces a Global Role as it Becomes Biggest Retina Meeting
Euretina openly embraced its identity as a global organization this year. Euretina has emerged since 2023 as the premier and largest meeting for retina doctors in the world. A record 11,144 people ...
11/20/2026
BiosimilarsBreakingDealsRetina
Sandoz Launches Enzeevu in the US, Announces Private Label Agreement
Sandoz Launches Enzeevu in the US, Announces Private Label Agreement
Swiss drugmaker Sandoz announced Nov. 16 the US launch of its Eylea biosimilar, Enzeevu (aflibercept-abzv) 2 mg, available in a pre-filled syringe. Enzeevu was approved in the US in August 2024. It...
11/20/2026
BreakingOptometry
High Point University Prepares to Open North Carolina’s First School of Optometry
High Point University Prepares to Open North Carolina’s First School of Optometry
North Carolina’s High Point University announced Nov. 12 that it had gained preliminary approval from the Accreditation Council on Optometric Education (ACOE), clearing the way for High Point to op...
11/20/2026
BreakingDealsGene TherapyRetina
Ocugen Licenses RP Gene Therapy Candidate to Celairis for Australia, New Zealand, ASEAN Countries
Ocugen Licenses RP Gene Therapy Candidate to Celairis for Australia, New Zealand, ASEAN Countries
Ocugen announced Nov. 10 that it had granted Australia’s Celairis Therapeutics exclusive rights to commercialize OCU400, Ocugen’s subretinal modifier gene therapy candidate targeting retinitis pigm...
11/20/2026
BreakingClinical TrialGene TherapyRegulationRetina
SparingVision Gets Green Light to Expand RP Gene Therapy Trial to US
SparingVision Gets Green Light to Expand RP Gene Therapy Trial to US
France’s SparingVision announced on LinkedIn on Nov. 12 that the FDA had signed off on its investigational new drug (IND) application, allowing the company to expand its clinical trial of SPVN20, a...

Provider Surveys & Interviews

Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Table of Innovation

Choose Your Own Adventure

Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.

Safe, Secure & On Any Device

We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.

Pre-Qualified Invitations

We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.

Better Data = Better Decisions

A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.

Market Scope+ App Screen

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Extensive analysis

  • Integrated disease models
  • Expert-based segmentation

Integrate and reconcile

  • Continuous feedback loop
  • Integration of survey data
  • Triangulation of results
  • Cross-model analysis
  • Reconciliation to company revenues

Produce products covering key medical markets

  • Medical devices
  • Drugs/biologics
  • Equipment
  • Providers

Gather feedback

  • New market insights
  • Client requests
  • Landmark study evaluations

Incorporate and revise

  • Forecasting models
  • Analytical tools and methods

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.